NO842003L - Substituerte isokinolinderivater - Google Patents

Substituerte isokinolinderivater

Info

Publication number
NO842003L
NO842003L NO842003A NO842003A NO842003L NO 842003 L NO842003 L NO 842003L NO 842003 A NO842003 A NO 842003A NO 842003 A NO842003 A NO 842003A NO 842003 L NO842003 L NO 842003L
Authority
NO
Norway
Prior art keywords
image
substituted
isoqinoline
derivatives
formula
Prior art date
Application number
NO842003A
Other languages
English (en)
Other versions
NO159271B (no
NO159271C (no
Inventor
Hans Hruderer
Richard Wightman Kierstead
John G Mullin Jr
Brien Jay Philip O
Sidney Teitel
Keiji Nakamura
Mitsuru Tateishi
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of NO842003L publication Critical patent/NO842003L/no
Publication of NO159271B publication Critical patent/NO159271B/no
Publication of NO159271C publication Critical patent/NO159271C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
    • C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
    • C07D295/205—Radicals derived from carbonic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/12—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with radicals, substituted by hetero atoms, attached to carbon atoms of the nitrogen-containing ring
    • C07D217/18—Aralkyl radicals
    • C07D217/20—Aralkyl radicals with oxygen atoms directly attached to the aromatic ring of said aralkyl radical, e.g. papaverine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C07D241/08—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members with oxygen atoms directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/22—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with hetero atoms directly attached to ring nitrogen atoms
    • C07D295/24—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
NO842003A 1983-05-19 1984-05-18 Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater. NO159271C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/496,327 US4544657A (en) 1983-05-19 1983-05-19 Substituted isoquinolines

Publications (3)

Publication Number Publication Date
NO842003L true NO842003L (no) 1984-11-20
NO159271B NO159271B (no) 1988-09-05
NO159271C NO159271C (no) 1988-12-14

Family

ID=23972146

Family Applications (1)

Application Number Title Priority Date Filing Date
NO842003A NO159271C (no) 1983-05-19 1984-05-18 Analogifremgangsmaate for fremstiling av terapeutisk aktive substituerte isokinolinderivater.

Country Status (20)

Country Link
US (1) US4544657A (no)
EP (1) EP0126480B1 (no)
JP (1) JPS59222478A (no)
KR (1) KR840009102A (no)
AT (1) ATE32072T1 (no)
AU (1) AU570044B2 (no)
CA (1) CA1243028A (no)
DE (1) DE3468875D1 (no)
DK (1) DK248484A (no)
ES (1) ES8601141A1 (no)
FI (1) FI81795C (no)
GR (1) GR82015B (no)
HU (1) HU192555B (no)
IL (1) IL71860A (no)
MC (1) MC1597A1 (no)
NO (1) NO159271C (no)
NZ (1) NZ208186A (no)
PH (1) PH19670A (no)
PT (1) PT78618A (no)
ZA (1) ZA843748B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2124511C1 (ru) * 1993-05-14 1999-01-10 Фармасьютикал Ко., Лтд Производные пиперазина
US5681954A (en) * 1993-05-14 1997-10-28 Daiichi Pharmaceutical Co., Ltd. Piperazine derivatives
EP0784474A2 (en) * 1994-10-05 1997-07-23 Glaxo Wellcome Inc. Parenteral pharmaceutical compositions containing gf120918a
FR2840896B1 (fr) * 2002-06-18 2005-04-08 Sanofi Synthelabo Phenyl-et pyridyl-piperazines, procede pour leur preparation et compositions pharmaceutiques les contenant
CN102295636A (zh) 2005-07-29 2011-12-28 弗·哈夫曼-拉罗切有限公司 吲哚-3-基-羰基-哌啶和哌嗪衍生物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759443A (fr) * 1970-09-15 1971-04-30 I F L O Istituto Farmacologico Nouveau derive papaverolinique et procede de preparation relatif
DE2818423A1 (de) * 1978-04-27 1979-11-08 Hoechst Ag Neue isochinolinderivate und verfahren zu ihrer herstellung
FI802117A7 (fi) * 1979-07-19 1981-01-01 Andre Buzas Menetelmä papaveriini-karbanionin valmistamiseksi.
DE3034001A1 (de) * 1980-09-10 1982-04-22 Hoechst Ag, 6000 Frankfurt Isochinolinderivate, verfahren zu ihrer hersellung, sie enthaltende pharmazeutische zubereitungen und ihre verwendung

Also Published As

Publication number Publication date
ZA843748B (en) 1985-01-30
GR82015B (no) 1984-12-12
PH19670A (en) 1986-06-09
JPS59222478A (ja) 1984-12-14
FI841992A7 (fi) 1984-11-20
FI841992A0 (fi) 1984-05-17
AU570044B2 (en) 1988-03-03
DK248484A (da) 1984-11-20
KR840009102A (ko) 1984-12-24
NO159271B (no) 1988-09-05
MC1597A1 (fr) 1985-05-09
CA1243028A (en) 1988-10-11
ES532603A0 (es) 1985-11-01
US4544657A (en) 1985-10-01
FI81795B (fi) 1990-08-31
HUT34185A (en) 1985-02-28
AU2835684A (en) 1984-11-22
HU192555B (en) 1987-06-29
EP0126480B1 (de) 1988-01-20
DK248484D0 (da) 1984-05-17
FI81795C (fi) 1990-12-10
EP0126480A1 (de) 1984-11-28
PT78618A (en) 1984-06-01
IL71860A0 (en) 1984-09-30
IL71860A (en) 1987-10-30
DE3468875D1 (en) 1988-02-25
NO159271C (no) 1988-12-14
ES8601141A1 (es) 1985-11-01
ATE32072T1 (de) 1988-02-15
NZ208186A (en) 1987-06-30

Similar Documents

Publication Publication Date Title
NO180166C (no) Pyrrolidin- og tiazolidinderivater samt medikamenter inneholdende forbindelsene
SE8502455L (sv) Aminocyklopentyletrar och deras framstellning samt farmaceutisk beredning
SE8502525L (sv) 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav
NO942606L (no) Anvendelse av fenalkylaminer
ES8601201A1 (es) Procedimiento para preparar derivados de imidazolina
AU570044B2 (en) Substituted isoquinoline derivatives
ATE188217T1 (de) 1,2,3,4,10,14b-hexahydrodibenzo-c,f)pyrazino-1, - a)azepino-derivate
ES2035915T3 (es) Agentes antiarritmicos n-fenetil-aminoalquil-benzamida.
DK283984A (da) Benzodiazepinderivater og fremgangsmaade til fremstilling deraf
ATE36325T1 (de) Derivate von 5-halovinyl-2'-deoxyuridin.
ATE17352T1 (de) Cephalosporinverbindungen, ihre herstellung und sie enthaltende medikamente.
GR79170B (no)
SE8400629L (sv) Basiska oximetrar
AU553351B2 (en) Organophosphate derivatives
SE8601963D0 (sv) O-sulfated beta-lactam hydroxamic acids
ES464483A1 (es) Procedimiento para la obtencion de ortoaminoacetofenonas.
ES519627A0 (es) Procedimiento para la preparacion de derivados de carbaciclina.
GB2021587A (en) Benzoquinolizines
DK159184A (da) Pterinforbindelser